Cryptic splicing sites are differentially utilized in vivo

FEBS Journal

Volumn 275, Issue 6, 2008, Pages 1150-1162

  Haj Khelil, Amel ^a,b   Deguillien, Mireille ^a   Morinière, Madeleine ^a   Ben Chibani, Jemni ^b   Baklouti, Faouzi ^a  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Cryptic splice site; Exon; Intron; mRNA splicing; Mutation

Indexed keywords

BETA GLOBIN; MESSENGER RNA;

5' UNTRANSLATED REGION; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CHROMOSOME; EX VIVO STUDY; EXON; GENE MUTATION; GENE SEQUENCE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; IN VIVO STUDY; INTRON; PRIORITY JOURNAL; RNA SPLICING; SPLICEOSOME; WILD TYPE;

EID: 40349087406     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2008.06276.x     Document Type: Article

References (66)

1. 1 Jurica MS & Moore MJ (2003) Pre‐mRNA splicing: awash in a sea of proteins. Mol Cell 12, 5–14.
2. 2 Mount SM (1982) A catalogue of splice junction sequences. Nucleic Acids Res 10, 459–472.
3. 3 Ohshima Y & Gotoh Y (1987) Signals for the selection of a splice site in pre‐mRNA. Computer analysis of splice junction sequences and like sequences. J Mol Biol 195, 247–259.
4. 4 Shapiro MB & Senapathy P (1987) RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 15, 7155–7174.
5. 5 Seraphin B, Kretzner L & Rosbash M (1988) A U1 snRNA:pre‐mRNA base pairing interaction is required early in yeast spliceosome assembly but does not uniquely define the 5′ cleavage site. EMBO J 7, 2533–2538.
6. 6 Siliciano PG & Guthrie C (1988) 5′ splice site selection in yeast: genetic alterations in base‐pairing with U1 reveal additional requirements. Genes Dev 2, 1258–1267.
7. 7 Zhuang Y & Weiner AM (1986) A compensatory base change in U1 snRNA suppresses a 5′ splice site mutation. Cell 46, 827–835.
8. 8 Freund M, Hicks MJ, Konermann C, Otte M, Hertel KJ & Schaal H (2005) Extended base pair complementarity between U1 snRNA and the 5′ splice site does not inhibit splicing in higher eukaryotes, but rather increases 5′ splice site recognition. Nucleic Acids Res 33, 5112–5119.
9. 9 Lund M & Kjems J (2002) Defining a 5′ splice site by functional selection in the presence and absence of U1 snRNA 5′ end. RNA 8, 166–179.
10. 10 Delhommeau F, Vasseur‐Godbillon C, Leclerc P, Schischmanoff PO, Croisille L, Rince P, Morinière M, Benz EJ Jr, Tchernia G, Tamagnini G et al. (2002) A splicing alteration of 4.1R pre‐mRNA generates 2 protein isoforms with distinct assembly to spindle poles in mitotic cells. Blood 100, 2629–2636.
11. 11 Morinière M, Ribeiro L, Dalla Venezia N, Deguillien M, Maillet P, Cynober T, Delhommeau F, Almeida H, Tamagnini G, Delaunay J et al. (2000) Elliptocytosis in patients with C‐terminal domain mutations of protein 4.1 correlates with encoded messenger RNA levels rather than with alterations in primary protein structure. Blood 95, 1834–1841.
12. 12 Buratti E, Baralle M & Baralle FE (2006) Defective splicing, disease and therapy: searching for master checkpoints in exon definition. Nucleic Acids Res 34, 3494–3510.
13. 13 Venables JP (2006) Unbalanced alternative splicing and its significance in cancer. Bioessays 28, 378–386.
14. 14 Buratti E & Baralle FE (2004) Influence of RNA secondary structure on the pre‐mRNA splicing process. Mol Cell Biol 24, 10505–10514.
15. 15 Faustino NA & Cooper TA (2003) Pre‐mRNA splicing and human disease. Genes Dev 17, 419–437.
16. 16 Kreahling JM & Graveley BR (2005) The iStem, a long‐range RNA secondary structure element required for efficient exon inclusion in the Drosophila Dscam pre‐mRNA. Mol Cell Biol 25, 10251–10260.
17. 17 Lenasi T, Peterlin BM & Dovc P (2006) Distal regulation of alternative splicing by splicing enhancer in equine beta‐casein intron 1. RNA 12, 498–507.
18. 18 Black DL (2003) Mechanisms of alternative pre‐messenger RNA splicing. Annu Rev Biochem 72, 291–336.
19. 19 Stamm S, Ben‐Ari S, Rafalska I, Tang Y, Zhang Z, Toiber D, Thanaraj TA & Soreq H (2005) Function of alternative splicing. Gene 344, 1–20.
20. 20 Maillet P, Dalla Venezia N, Lorenzo F, Moriniere M, Bozon M, Noel B, Delaunay J & Baklouti F (1999) A premature termination codon within an alternative exon affecting only the metabolism of transcripts that retain this exon. Hum Mutat 14, 145–155.
21. 21 Krawczak M, Thomas NS, Hundrieser B, Mort M, Wittig M, Hampe J & Cooper DN (2007) Single base‐pair substitutions in exon‐intron junctions of human genes: nature, distribution, and consequences for mRNA splicing. Hum Mutat 28, 150–158.
22. 22 Eskesen ST, Eskesen FN & Ruvinsky A (2004) Natural selection affects frequencies of AG and GT dinucleotides at the 5′ and 3′ ends of exons. Genetics 167, 543–550.
23. 23 Sadusky T, Newman AJ & Dibb NJ (2004) Exon junction sequences as cryptic splice sites: implications for intron origin. Curr Biol 14, 505–509.
24. 24 Sun H & Chasin LA (2000) Multiple splicing defects in an intronic false exon. Mol Cell Biol 20, 6414–6425.
25. 25 Kralovicova J, Christensen MB & Vorechovsky I (2005) Biased exon/intron distribution of cryptic and de novo 3′ splice sites. Nucleic Acids Res 33, 4882–4898.
26. 26 Roca X, Sachidanandam R & Krainer AR (2003) Intrinsic differences between authentic and cryptic 5′ splice sites. Nucleic Acids Res 31, 6321–6333.
27. 27 Nelson KK & Green MR (1990) Mechanism for cryptic splice site activation during pre‐mRNA splicing. Proc Natl Acad Sci USA 87, 6253–6257.
28. 28 Treisman R, Orkin SH & Maniatis T (1983) Specific transcription and RNA splicing defects in five cloned beta‐thalassaemia genes. Nature 302, 591–596.
29. 29 Krainer AR, Maniatis T, Ruskin B & Green MR (1984) Normal and mutant human beta‐globin pre‐mRNAs are faithfully and efficiently spliced in vitro. Cell 36, 993–1005.
30. 30 Lapoumeroulie C, Pagnier J, Bank A, Labie D & Krishnamoorthy R (1986) Beta thalassemia due to a novel mutation in IVS 1 sequence donor site consensus sequence creating a restriction site. Biochem Biophys Res Commun 139, 709–713.
31. 31 Deguillien M, Huang SC, Morinière M, Dreumont N, Benz EJ Jr & Baklouti F (2001) Multiple cis elements regulate an alternative splicing event at 4.1R pre‐mRNA during erythroid differentiation. Blood 98, 3809–3816.
32. 32 Kornblihtt AR, de la Mata M, Fededa JP, Munoz MJ & Nogues G (2004) Multiple links between transcription and splicing. RNA 10, 1489–1498.
33. 33 Maquat LE (2004) Nonsense‐mediated mRNA decay: splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol 5, 89–99.
34. 34 Reed R (2003) Coupling transcription, splicing and mRNA export. Curr Opin Cell Biol 15, 326–331.
35. 35 Starck J, Doubeikovski A, Sarrazin S, Gonnet C, Rao G, Skoultchi A, Godet J, Dusanter‐Fourt I & Morle F (1999) Spi‐1/PU.1 is a positive regulator of the Fli‐1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines. Mol Cell Biol 19, 121–135.
36. 36 Needham M, Gooding C, Hudson K, Antoniou M, Grosveld F & Hollis M (1992) LCR/MEL: a versatile system for high‐level expression of heterologous proteins in erythroid cells. Nucleic Acids Res 20, 997–1003.
37. 37 Tewari R, Gillemans N, Wijgerde M, Nuez B, von Lindern M, Grosveld F & Philipsen S (1998) Erythroid Kruppel‐like factor (EKLF) is active in primitive and definitive erythroid cells and is required for the function of 5′HS3 of the beta‐globin locus control region. EMBO J 17, 2334–2341.
38. 38 Wieringa B, Meyer F, Reiser J & Weissmann C (1983) Unusual splice sites revealed by mutagenic inactivation of an authentic splice site of the rabbit beta‐globin gene. Nature 301, 38–43.
39. 39 Schaal TD & Maniatis T (1999) Multiple distinct splicing enhancers in the protein‐coding sequences of a constitutively spliced pre‐mRNA. Mol Cell Biol 19, 261–273.
40. 40 Steijlen PM, van Steensel MA, Jansen BJ, Blokx W, van de Kerkhof PC, Happle R & van Geel M (2004) Cryptic splicing at a non‐consensus splice‐donor in a patient with a novel mutation in the plakophilin‐1 gene. J Invest Dermatol 122, 1321–1324.
41. 41 Bradley KJ, Cavaco BM, Bowl MR, Harding B, Young A & Thakker RV (2005) Utilisation of a cryptic non‐canonical donor splice site of the gene encoding PARAFIBROMIN is associated with familial isolated primary hyperparathyroidism. J Med Genet 42, E51.
42. 42 Hastings ML, Resta N, Traum D, Stella A, Guanti G & Krainer AR (2005) An LKB1 AT‐AC intron mutation causes Peutz‐Jeghers syndrome via splicing at noncanonical cryptic splice sites. Nat Struct Mol Biol 12, 54–59.
43. 43 Chabot B & Steitz JA (1987) Recognition of mutant and cryptic 5′ splice sites by the U1 small nuclear ribonucleoprotein in vitro. Mol Cell Biol 7, 698–707.
44. 44 Gardella R, Belletti L, Zoppi N, Marini D, Barlati S & Colombi M (1996) Identification of two splicing mutations in the collagen type VII gene (COL7A1) of a patient affected by the localisata variant of recessive dystrophic epidermolysis bullosa. Am J Hum Genet 59, 292–300.
45. 45 Nagy E & Maquat LE (1998) A rule for termination‐codon position within intron‐containing genes: when nonsense affects RNA abundance. Trends Biochem Sci 23, 198–199.
46. 46 Li B, Wachtel C, Miriami E, Yahalom G, Friedlander G, Sharon G, Sperling R & Sperling J (2002) Stop codons affect 5′ splice site selection by surveillance of splicing. Proc Natl Acad Sci USA 99, 5277–5282.
47. 47 Miriami E, Motro U, Sperling J & Sperling R (2002) Conservation of an open‐reading frame as an element affecting 5′ splice site selection. J Struct Biol 140, 116–122.
48. 48 Romao L, Inacio A, Santos S, Avila M, Faustino P, Pacheco P & Lavinha J (2000) Nonsense mutations in the human beta‐globin gene lead to unexpected levels of cytoplasmic mRNA accumulation. Blood 96, 2895–2901.
49. 49 Danckwardt S, Neu‐Yilik G, Thermann R, Frede U, Hentze MW & Kulozik AE (2002) Abnormally spliced beta‐globin mRNAs: a single point mutation generates transcripts sensitive and insensitive to nonsense‐mediated mRNA decay. Blood 99, 1811–1816.
50. 50 Alvarez CJ & Wise JA (2001) Activation of a cryptic 5′ splice site by U1 snRNA. RNA 7, 342–350.
51. 51 Du H & Rosbash M (2002) The U1 snRNP protein U1C recognizes the 5′ splice site in the absence of base pairing. Nature 419, 86–90.
52. 52 Crispino JD, Blencowe BJ & Sharp PA (1994) Complementation by SR proteins of pre‐mRNA splicing reactions depleted of U1 snRNP. Science 265, 1866–1869.
53. 53 Tarn WY & Steitz JA (1994) SR proteins can compensate for the loss of U1 snRNP functions in vitro. Genes Dev 8, 2704–2717.
54. 54 Caceres JF, Stamm S, Helfman DM & Krainer AR (1994) Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265, 1706–1709.
55. 55 Krainer AR, Conway GC & Kozak D (1990) The essential pre‐mRNA splicing factor SF2 influences 5′ splice site selection by activating proximal sites. Cell 62, 35–42.
56. 56 Mayeda A & Krainer AR (1992) Regulation of alternative pre‐mRNA splicing by hnRNP A1 and splicing factor SF2. Cell 68, 365–375.
57. 57 Gabut M, Mine M, Marsac C, Brivet M, Tazi J & Soret J (2005) The SR protein SC35 is responsible for aberrant splicing of the E1alpha pyruvate dehydrogenase mRNA in a case of mental retardation with lactic acidosis. Mol Cell Biol 25, 3286–3294.
58. 58 Spena S, Tenchini ML & Buratti E (2006) Cryptic splice site usage in exon 7 of the human fibrinogen Bbeta‐chain gene is regulated by a naturally silent SF2/ASF binding site within this exon. RNA 12, 948–958.
59. 59 Domenjoud L, Gallinaro H, Kister L, Meyer S & Jacob M (1991) Identification of a specific exon sequence that is a major determinant in the selection between a natural and a cryptic 5′ splice site. Mol Cell Biol 11, 4581–4590.
60. 60 Nissim‐Rafinia M & Kerem B (2005) The splicing machinery is a genetic modifier of disease severity. Trends Genet 21, 480–483.
61. 61 Xia H, Bi J & Li Y (2006) Identification of alternative 5′/3′ splice sites based on the mechanism of splice site competition. Nucleic Acids Res 34, 6305–6313.
62. 62 Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, Redon R, Bird CP, de Grassi A, Lee C et al. (2007) Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315, 848–853.
63. 63 Hull J, Campino S, Rowlands K, Chan MS, Copley RR, Taylor MS, Rockett K, Elvidge G, Keating B, Knight J et al. (2007) Identification of common genetic variation that modulates alternative splicing. PLoS Genet 3, E99.
64. 64 Kwan T, Benovoy D, Dias C, Gurd S, Serre D, Zuzan H, Clark TA, Schweitzer A, Staples MK, Wang H et al. (2007) Heritability of alternative splicing in the human genome. Genome Res 17, 1210–1218.
65. 65 Liebhaber SA & Kan YW (1982) Different rates of mRNA translation balance the expression of the two human alpha‐globin loci. J Biol Chem 257, 11852–11855.
66. 66 Maillet P, Delaunay J & Baklouti F (1996) Chimeric probe‐mediated ribonuclease protection assay for molecular diagnosis of mRNA deficiencies. Hum Mutat 7, 61–64.